{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"SAB Bio\u2019s Safeguard Study: A New Way to Approach Type 1 Diabetes Delay and Prevention","description":"What's next in the attempt to change the course of type 1 diabetes?  SAB Bio says they\u2019re looking to redefine what it means to get a type 1 diabetes diagnosis. They\u2019re trialing a drug right now preserve the patient's ability to make their own insulin.. and maybe even allow repeat dosing. I\u2019m talking to Dr. Michael Haller from the University of Florida and Sam Reich the CEO of SAB Bio about what makes this different and what their big hopes are. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  ","author_name":"Diabetes Connections | Type 1 Diabetes","author_url":"https:\/\/www.diabetes-connections.com","html":"